Scarica l'app Stockscreener
2.7092
0.40%
0.0192
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
What makes Achieve Life Sciences Inc. stock price move sharplyFree Discussion Group - Newser
How Achieve Life Sciences Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser
Why Achieve Life Sciences Inc. stock attracts strong analyst attentionWealth Building Stock Portfolio - Newser
Company’s Banking Shares: Up -49.72% from 52-Week Low, But Can the Momentum Hold? - investchronicle.com
Omnicom, Achieve Life Sciences Partner for AI-Driven Launch of New Nicotine Dependence Treatment - MSN
Achieve Life Sciences: The AI-Powered Push to Redefine Smoking Cessation - AInvest
Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation - Seeking Alpha
Should You Hold Achieve Life Sciences (ACHV)? - Insider Monkey
ACHV: Achieve’s Busy Day - Yahoo Finance
Achieve Life Sciences (ACHV) Receives a Buy from Raymond James - The Globe and Mail
Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering - MSN
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities | ACHV Stock News - GuruFocus
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) dropped from Russell 3000 Index - MarketScreener
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) dropped from Russell 3000 Growth Index - MarketScreener
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) dropped from Russell 2500 Index - MarketScreener
Bothell biotech firm plans $45 million public offering to advance smoking cessation drug - The Business Journals
Tech And Biotech Stocks Take A Dive Following Surprising Announcements - Finimize
Achieve Life Sciences (ACHV) Submits FDA Application for Smoking Cessation Drug | ACHV Stock News - GuruFocus
ACHV Gains Attention with Strategic Financial Moves | ACHV Stock News - GuruFocus
Achieve Life Sciences (ACHV) Launches $45 Million Stock Offering - GuruFocus
Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation - The Manila Times
Achieve Life Sciences Announces Pricing of $45.0 Million Underwr - GuruFocus
Achieve Life Sciences announces proposed public offering; shares down nearly 13% - MSN
Achieve Life Sciences announces public offering to fund cytisinicline By Investing.com - Investing.com UK
Achieve Life Sciences Announces Submission of NDA to FDA - GlobeNewswire
Achieve Life Sciences names Omnicom as strategic partner for launch - Investing.com
Achieve adds vapers to smokers in targeting multi-billion dollar market - The Pharma Letter
Bank of America Corp DE Purchases 9,760 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Institutional investors may adopt severe steps after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) latest 15% drop adds to a year losses - simplywall.st
Owning 46% shares,institutional owners seem interested in Achieve Life Sciences, Inc. (NASDAQ:ACHV), - Yahoo
Squarepoint Ops LLC Buys Shares of 17,519 Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
achieve life sciences holds annual meeting with key votes By Investing.com - Investing.com India
Achieve Life Sciences Elects Board at Annual Meeting - TipRanks
achieve life sciences holds annual meeting with key votes - Investing.com
Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk (ACHV) - Seeking Alpha
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - GlobeNewswire
Late-Stage Smoking Cessation Drug Developer Achieve Life Sciences Sets Key Jefferies Conference Presentation - Stock Titan
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Shares Purchased by Northern Trust Corp - Defense World
Shay Capital LLC Sells 425,000 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
ACHV: New Insights from ORCA-3 Study to Be Shared at 2025 Conference | ACHV Stock News - GuruFocus
Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake | ACHV Stock News - GuruFocus
Achieve Life Sciences to Present Phase 3 Study Findings on Cytisinicline for Smoking Cessation at 2025 ATS Conference - Nasdaq
Achieve Life Sciences to Present New Data at the 2025 ATS - GlobeNewswire
New Clinical Data Shows Cytisinicline Cuts Nicotine Cravings in Phase 3 Trial | ACHV Stock News - Stock Titan
Brokers Offer Predictions for ACHV Q3 Earnings - Defense World
Tower Research Capital LLC TRC Acquires 4,905 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
What is Zacks Small Cap’s Estimate for ACHV Q2 Earnings? - Defense World
Achieve Life Sciences targets NDA submission for cytisinicline in June 2025 as open label study hits key milestones - MSN
Raymond James Financial Inc. Purchases New Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
3.69%
2.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):